Biomea Fusion, Inc. (BMEA) stock
BMEANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.56−0.05 (-7.89%)
Close on Nov 12, 2026Market cap $40.79MP/E –Yield –
Biomea Fusion pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
No pe ratio figures for Biomea Fusion
Biomea Fusion has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?